AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/140
RECURRENT DEPRESSION, RESISTANT CLINICIAN
Authors: FREDMAN SJ ROSENBAUM JF
Citation: Sj. Fredman et Jf. Rosenbaum, RECURRENT DEPRESSION, RESISTANT CLINICIAN, Harvard review of psychiatry, 5(5), 1998, pp. 281-285
DOPAMINERGIC AGENTS AND STIMULANTS AS ANTIDEPRESSANT AUGMENTATION STRATEGIES
Authors: NIERENBERG AA DOUGHERTY D ROSENBAUM JF
Citation: Aa. Nierenberg et al., DOPAMINERGIC AGENTS AND STIMULANTS AS ANTIDEPRESSANT AUGMENTATION STRATEGIES, The Journal of clinical psychiatry, 59, 1998, pp. 60-64
PSYCHOTROPIC-DRUG USE DURING PREGNANCY - WEIGHING THE RISKS
Authors: COHEN LS ROSENBAUM JF
Citation: Ls. Cohen et Jf. Rosenbaum, PSYCHOTROPIC-DRUG USE DURING PREGNANCY - WEIGHING THE RISKS, The Journal of clinical psychiatry, 59, 1998, pp. 18-28
MANAGED CARE VERSUS MANAGED MONEY - INTRODUCTION
Authors: GLAZER WM ROSENBAUM JF
Citation: Wm. Glazer et Jf. Rosenbaum, MANAGED CARE VERSUS MANAGED MONEY - INTRODUCTION, The Journal of clinical psychiatry, 59, 1998, pp. 62-62
MANAGED CARE VERSUS MANAGED MONEY
Authors: GLAZER WM ROSENBAUM JF
Citation: Wm. Glazer et Jf. Rosenbaum, MANAGED CARE VERSUS MANAGED MONEY, The Journal of clinical psychiatry, 59, 1998, pp. 62-66
ROLE OF MEDICATION IN MANAGED CARE FOR DEPRESSION
Authors: GLAZER WM ROSENBAUM JF
Citation: Wm. Glazer et Jf. Rosenbaum, ROLE OF MEDICATION IN MANAGED CARE FOR DEPRESSION, The Journal of clinical psychiatry, 59, 1998, pp. 67-67
ROLE OF PSYCHIATRISTS IN MANAGED CARE SYSTEMS
Authors: GLAZER WM ROSENBAUM JF
Citation: Wm. Glazer et Jf. Rosenbaum, ROLE OF PSYCHIATRISTS IN MANAGED CARE SYSTEMS, The Journal of clinical psychiatry, 59, 1998, pp. 68-68
COURSE AND TREATMENT OF ATYPICAL DEPRESSION
Authors: NIERENBERG AA ALPERT JE PAVA J ROSENBAUM JF FAVA M
Citation: Aa. Nierenberg et al., COURSE AND TREATMENT OF ATYPICAL DEPRESSION, The Journal of clinical psychiatry, 59, 1998, pp. 5-9
DEPRESSION AND ITS SUBTYPES - A TREATMENT UPDATE
Authors: ROSENBAUM JF
Citation: Jf. Rosenbaum, DEPRESSION AND ITS SUBTYPES - A TREATMENT UPDATE, The Journal of clinical psychiatry, 59, 1998, pp. 37-38
A NEW STRATEGY FOR THE GENETIC-ANALYSIS OF ANXIOUS TEMPERAMENT
Authors: SMOLLER JW ROSENBAUM JF BIEDERMAN JB KAGAN J SUSSWEIN L HELBLING L SLAUGENHAUPT S
Citation: Jw. Smoller et al., A NEW STRATEGY FOR THE GENETIC-ANALYSIS OF ANXIOUS TEMPERAMENT, American journal of medical genetics, 81(6), 1998, pp. 488-488
SELECTIVE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME - A RANDOMIZED CLINICAL-TRIAL
Authors: ROSENBAUM JF FAVA M HOOG SL ASCROFT RC KREBS WB
Citation: Jf. Rosenbaum et al., SELECTIVE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME - A RANDOMIZED CLINICAL-TRIAL, Biological psychiatry, 44(2), 1998, pp. 77-87
FLUOXETINE VERSUS SERTRALINE AND PAROXETINE IN MAJOR DEPRESSION - SAFETY AND EFFICACY IN PATIENTS WITH LOW AND HIGH BASE-LINE INSOMNIA
Authors: FAVA M ROSENBAUM JF HOOG S TEPNER R KOPP J SAYLER M
Citation: M. Fava et al., FLUOXETINE VERSUS SERTRALINE AND PAROXETINE IN MAJOR DEPRESSION - SAFETY AND EFFICACY IN PATIENTS WITH LOW AND HIGH BASE-LINE INSOMNIA, Biological psychiatry, 43, 1998, pp. 341-341
FLUOXETINE VERSUS SERTRALINE AND PAROXETINE IN MAJOR DEPRESSION - SAFETY AND EFFICACY IN ANXIOUS AND NONANXIOUS SUBGROUPS
Authors: FAVA M ROSENBAUM JF HOOG S TEPNER R KOPP J SAYLER M
Citation: M. Fava et al., FLUOXETINE VERSUS SERTRALINE AND PAROXETINE IN MAJOR DEPRESSION - SAFETY AND EFFICACY IN ANXIOUS AND NONANXIOUS SUBGROUPS, Biological psychiatry, 43, 1998, pp. 342-342
OPTIMAL LENGTH OF CONTINUATION THERAPY IN DEPRESSION - A PROSPECTIVE ASSESSMENT DURING LONG-TERM FLUOXETINE TREATMENT
Authors: REIMHERR FW AMSTERDAM JD QUITKIN FM ROSENBAUM JF FAVA M ZAJECKA J BEASLEY CM MICHELSON D ROBACK P SUNDELL K
Citation: Fw. Reimherr et al., OPTIMAL LENGTH OF CONTINUATION THERAPY IN DEPRESSION - A PROSPECTIVE ASSESSMENT DURING LONG-TERM FLUOXETINE TREATMENT, The American journal of psychiatry, 155(9), 1998, pp. 1247-1253
FLUOXETINE AND NORFLUOXETINE - DR. AMSTERDAM AND COLLEAGUES REPLY
Authors: AMSTERDAM JD FAWCETT J QUITKIN FM REIMHERR FW ROSENBAUM JF MICHELSON D BEASLEY CM
Citation: Jd. Amsterdam et al., FLUOXETINE AND NORFLUOXETINE - DR. AMSTERDAM AND COLLEAGUES REPLY, The American journal of psychiatry, 155(11), 1998, pp. 1637-1637
EXPRESSED EMOTION TOWARD CHILDREN WITH BEHAVIORAL-INHIBITION - ASSOCIATIONS WITH MATERNAL ANXIETY DISORDER
Authors: HIRSHFELD DR BIEDERMAN J BRODY L FARAONE SV ROSENBAUM JF
Citation: Dr. Hirshfeld et al., EXPRESSED EMOTION TOWARD CHILDREN WITH BEHAVIORAL-INHIBITION - ASSOCIATIONS WITH MATERNAL ANXIETY DISORDER, Journal of the American Academy of Child and Adolescent Psychiatry, 36(7), 1997, pp. 910-917
ASSOCIATIONS BETWEEN EXPRESSED EMOTION AND CHILD BEHAVIORAL-INHIBITION AND PSYCHOPATHOLOGY - A PILOT-STUDY
Authors: HIRSHFELD DR BIEDERMAN J BRODY L FARAONE SV ROSENBAUM JF
Citation: Dr. Hirshfeld et al., ASSOCIATIONS BETWEEN EXPRESSED EMOTION AND CHILD BEHAVIORAL-INHIBITION AND PSYCHOPATHOLOGY - A PILOT-STUDY, Journal of the American Academy of Child and Adolescent Psychiatry, 36(2), 1997, pp. 205-213
ARE DEPENDENCY AND SELF-CRITICISM RISK-FACTORS FOR MAJOR DEPRESSIVE DISORDER
Authors: ZARETSKY AE FAVA M DAVIDSON KG PAVA JA MATTHEWS J ROSENBAUM JF
Citation: Ae. Zaretsky et al., ARE DEPENDENCY AND SELF-CRITICISM RISK-FACTORS FOR MAJOR DEPRESSIVE DISORDER, Canadian journal of psychiatry, 42(3), 1997, pp. 291-297
CLONAZEPAM IN THE TREATMENT OF PANIC-DISORDER WITH OR WITHOUT AGORAPHOBIA - A DOSE-RESPONSE STUDY OF EFFICACY, SAFETY, AND DISCONTINUANCE
Authors: ROSENBAUM JF MOROZ G BOWDEN CL
Citation: Jf. Rosenbaum et al., CLONAZEPAM IN THE TREATMENT OF PANIC-DISORDER WITH OR WITHOUT AGORAPHOBIA - A DOSE-RESPONSE STUDY OF EFFICACY, SAFETY, AND DISCONTINUANCE, Journal of clinical psychopharmacology, 17(5), 1997, pp. 390-400
SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME - A HYPOTHETICAL DEFINITION
Authors: SCHATZBERG AF HADDAD P KAPLAN EM LEJOYEUX M ROSENBAUM JF YOUNG AH ZAJECKA J
Citation: Af. Schatzberg et al., SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME - A HYPOTHETICAL DEFINITION, The Journal of clinical psychiatry, 58, 1997, pp. 5-10
POSSIBLE BIOLOGICAL MECHANISMS OF THE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME
Authors: SCHATZBERG AF HADDAD P KAPLAN EM LEJOYEUX M ROSENBAUM JF YOUNG AH ZAJECKA J
Citation: Af. Schatzberg et al., POSSIBLE BIOLOGICAL MECHANISMS OF THE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME, The Journal of clinical psychiatry, 58, 1997, pp. 23-27
CLINICAL MANAGEMENT OF ANTIDEPRESSANT DISCONTINUATION
Authors: ROSENBAUM JF ZAJECKA J
Citation: Jf. Rosenbaum et J. Zajecka, CLINICAL MANAGEMENT OF ANTIDEPRESSANT DISCONTINUATION, The Journal of clinical psychiatry, 58, 1997, pp. 37-40
TREATMENT OF PANIC DISORDER - THE STATE-OF-THE-ART - INTRODUCTION
Authors: ROSENBAUM JF
Citation: Jf. Rosenbaum, TREATMENT OF PANIC DISORDER - THE STATE-OF-THE-ART - INTRODUCTION, The Journal of clinical psychiatry, 58, 1997, pp. 3-3
TREATMENT-RESISTANT PANIC DISORDER
Authors: ROSENBAUM JF
Citation: Jf. Rosenbaum, TREATMENT-RESISTANT PANIC DISORDER, The Journal of clinical psychiatry, 58, 1997, pp. 61-65
TREATMENT OF PANIC DISORDER - THE STATE-OF-THE-ART - CONCLUSION
Authors: ROSENBAUM JF
Citation: Jf. Rosenbaum, TREATMENT OF PANIC DISORDER - THE STATE-OF-THE-ART - CONCLUSION, The Journal of clinical psychiatry, 58, 1997, pp. 66-67
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>